FOXO3 and central nervous system cancer: FoxO3 transcriptional activity attenuates ROS levels, reducing HIF-1α stabilization in normal cells, however as FoxO3 activity is often downregulated due to oncogenic signaling, HIF-1 is further stabilized by increased ROS tolerance in glioma (Ferber et al., 2012).